Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma

British Journal of Radiology

Volumn 84, Issue 1001, 2011, Pages

  Thavendiranathan, P ^a   Verhaert, D ^a   Kendra, K L ^a   Raman, Subha V ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; GADOBENATE DIMEGLUMINE; INTERLEUKIN 2; LISINOPRIL; METOPROLOL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CARDIAC IMAGING; CASE REPORT; CHILL; CONTRAST ENHANCEMENT; DIARRHEA; DISEASE SEVERITY; DRUG MEGADOSE; DYSPNEA; FATIGUE; FEVER; FLUSHING; FULMINANT HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMATOLOGY; HUMAN; LEUKOCYTOSIS; MALE; MELANOMA; METASTASIS; MYOCARDITIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; RIGOR; SIDE EFFECT; TACHYCARDIA; VOMITING;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; GADOLINIUM; HUMANS; INTERLEUKIN-2; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; MYOCARDITIS; TREATMENT OUTCOME;

EID: 79955081527     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/13448473     Document Type: Article

References (9)

1. Cooper LT, Jr. Myocarditis. N Engl J Med 2009;360:1526-38.
2. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Jr., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
3. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007;50:1914-31. (Pubitemid 350011209)
4. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53:1475-87.
5. Atkins MB, Kunkel L, Sznol M, Rosenberg SA. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am 2000;6 (Suppl 1):S11-14.
6. Eisner RM, Husain A, Clark JI. Case report and brief review: IL-2-induced myocarditis. Cancer Invest 2004;22:401-4. (Pubitemid 39310910)
7. Zhang J, Yu ZX, Hilbert SL, Yamaguchi M, Chadwick DP, Herman EH, et al. Cardiotoxicity of human recombinant interleukin-2 in rats. A morphological study. Circulation 1993;87:1340-53. (Pubitemid 23110405)
8. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007;26:452-9. (Pubitemid 350194566)
9. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction. Current and emerging applications. J Am Coll Cardiol 2010;55:1-16.